These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 22262002)

  • 1. Type 2 diabetes and bone fractures.
    Moseley KF
    Curr Opin Endocrinol Diabetes Obes; 2012 Apr; 19(2):128-35. PubMed ID: 22262002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of diabetes mellitus-induced bone fragility.
    Napoli N; Chandran M; Pierroz DD; Abrahamsen B; Schwartz AV; Ferrari SL;
    Nat Rev Endocrinol; 2017 Apr; 13(4):208-219. PubMed ID: 27658727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 2 diabetes mellitus and bone.
    Compston J
    J Intern Med; 2018 Feb; 283(2):140-153. PubMed ID: 29265670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fracture Risk Assessment in Patients With Diabetes Mellitus.
    Poiana C; Capatina C
    J Clin Densitom; 2017; 20(3):432-443. PubMed ID: 28716499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiology and Management of Type 2 Diabetes Mellitus Bone Fragility.
    Eller-Vainicher C; Cairoli E; Grassi G; Grassi F; Catalano A; Merlotti D; Falchetti A; Gaudio A; Chiodini I; Gennari L
    J Diabetes Res; 2020; 2020():7608964. PubMed ID: 32566682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes, fracture, and bone fragility.
    Schwartz AV; Sellmeyer DE
    Curr Osteoporos Rep; 2007 Sep; 5(3):105-11. PubMed ID: 17925191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of diabetes and its treatments on skeletal diseases.
    Yan W; Li X
    Front Med; 2013 Mar; 7(1):81-90. PubMed ID: 23377889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of diabetes and diabetes medications on bone health.
    Gilbert MP; Pratley RE
    Endocr Rev; 2015 Apr; 36(2):194-213. PubMed ID: 25738213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosiglitazone and pioglitazone increase fracture risk in women and men with type 2 diabetes.
    Aubert RE; Herrera V; Chen W; Haffner SM; Pendergrass M
    Diabetes Obes Metab; 2010 Aug; 12(8):716-21. PubMed ID: 20590749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diabetes increases the risk of fractures].
    Starup-Linde J; Karahasanovic A; Vestergaard P; Eiken P
    Ugeskr Laeger; 2015 Nov; 177(49):V08150663. PubMed ID: 26651553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thiazolidinedione-induced skeletal fragility--mechanisms and implications.
    Grey A
    Diabetes Obes Metab; 2009 Apr; 11(4):275-84. PubMed ID: 18671797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Thiazolidinediones and skeletal health].
    Meier C; Bodmer M; Meier CR; Kraenzlin ME
    Rev Med Suisse; 2009 Jun; 5(207):1309-10, 1312-3. PubMed ID: 19626930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The risks of sarcopenia, falls and fractures in patients with type 2 diabetes mellitus.
    Sarodnik C; Bours SPG; Schaper NC; van den Bergh JP; van Geel TACM
    Maturitas; 2018 Mar; 109():70-77. PubMed ID: 29452785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone as a target of type 2 diabetes treatment.
    Lecka-Czernik B
    Curr Opin Investig Drugs; 2009 Oct; 10(10):1085-90. PubMed ID: 19777397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of bone microstructure, and treatment of bone fragility in chronic kidney disease.
    Seeman E
    Nephrology (Carlton); 2017 Mar; 22 Suppl 2():34-35. PubMed ID: 28429552
    [No Abstract]   [Full Text] [Related]  

  • 16. Glycemic Control with Thiazolidinedione Is Associated with Fracture of T2DM Patients.
    Chen HH; Horng MH; Yeh SY; Lin IC; Yeh CJ; Muo CH; Sung FC; Kao CH
    PLoS One; 2015; 10(8):e0135530. PubMed ID: 26317995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk Factors for Incident Falls and Fractures in Older Men With and Without Type 2 Diabetes Mellitus: The Concord Health and Ageing in Men Project.
    Mesinovic J; Scott D; Seibel MJ; Cumming RG; Naganathan V; Blyth FM; Le Couteur DG; Waite LM; Handelsman DJ; Hirani V
    J Gerontol A Biol Sci Med Sci; 2021 May; 76(6):1090-1100. PubMed ID: 33649759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidiabetic therapy effects on bone metabolism and fracture risk.
    Montagnani A; Gonnelli S
    Diabetes Obes Metab; 2013 Sep; 15(9):784-91. PubMed ID: 23368527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes mellitus, bone mineral density, and fracture risk.
    Strotmeyer ES; Cauley JA
    Curr Opin Endocrinol Diabetes Obes; 2007 Dec; 14(6):429-35. PubMed ID: 17982347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type 2 diabetes and bone fragility- An under-recognized association.
    Farooqui KJ; Mithal A; Kerwen AK; Chandran M
    Diabetes Metab Syndr; 2021; 15(3):927-935. PubMed ID: 33932745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.